NanoViricides Inc. (NNVC): No its not. Having a version of the dru...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Friday, 05/31/2013 4:50:57 PM

Friday, May 31, 2013 4:50:57 PM

No its not. Having a version of the drug you intend to put into clinical trials is precisely the point of the lab work.

Keep Last Read

Replies (1) Next 10 Prev Next

Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/15/2024 08:44:44 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/27/2024 08:15:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM

InvestorsHub NewsWire

Only $200 per official company press release!